#1 ProtocolClav's Stack
−28.7%Weight Loss Data
24+Peptides Available
>98%HPLC Purity
$200+Free Shipping
ApolloVerified Supplier
Back to Guides

GHK-CU: The Copper Peptide Research Guide (GLOW Explained)

Complete GHK-CU copper peptide research guide — collagen synthesis, skin remodeling, wound healing, hair follicle stimulation, and the science behind the GLOW effect in the Clavicular Stack.

What Is GHK-CU?

GHK-CU (Copper peptide GHK-CU, or glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper complex found in human plasma, saliva, and urine. Plasma concentrations decline significantly with age — from ~200 ng/mL at age 20 to ~80 ng/mL by age 60 — which has driven research interest in exogenous administration for skin remodeling and tissue repair.

In the Clavicular Stack, GHK-CU is the "GLOW" peptide — named for the visible skin improvement seen when copper peptide is run alongside fat loss.

Molecular Profile

  • Structure: Tripeptide-copper complex (Gly-His-Lys + Cu2+)
  • Molecular weight: 340.38 Da
  • Natural source: Human plasma, derived from the albumin N-terminus
  • CAS number: 89030-95-5
  • Stability: Stable when protected from light and moisture

Mechanisms of Action

Collagen & Elastin Synthesis

GHK-CU upregulates collagen types I, III, VI and elastin gene expression in fibroblasts. Studies show:
  • Up to 70% increase in collagen production at 1-10 nM concentrations
  • Enhanced elastin synthesis and glycosaminoglycan production
  • Increased fibroblast proliferation and migration

Skin Remodeling

GHK-CU activates matrix metalloproteinases (MMPs) that break down damaged, cross-linked collagen, while simultaneously upregulating collagen synthesis genes. This dual action remodels the extracellular matrix:
  • Removal of aged/damaged collagen fibers
  • Deposition of new organized collagen
  • Improved skin firmness and texture

Wound Healing & Angiogenesis

GHK-CU accelerates wound healing through multiple pathways:
  • VEGF upregulation → increased capillary density at wound site
  • Anti-inflammatory signaling → reduced wound inflammation
  • Keratinocyte proliferation → faster epithelial closure
  • Enhanced platelet aggregation at wound edges

Antioxidant Activity

Copper in GHK-CU activates superoxide dismutase (Cu-SOD), the primary cellular defense against reactive oxygen species. This antioxidant function protects skin cells from UV and oxidative damage.

Hair Follicle Stimulation

GHK-CU has been studied for androgenic alopecia research. Mechanisms include:
  • Upregulation of VEGF in follicle dermal papilla cells
  • Enhanced follicle size (from vellus to terminal)
  • Reduction of DHT-induced follicle miniaturization markers

Research Dosing

Reconstitution Protocol (50mg Vial)

  • Add 10mL bacteriostatic water → 5mg/mL (5000mcg/mL)
  • For 1mg topical or subQ research dose: draw 0.2mL
  • For 2mg research dose: draw 0.4mL
Routes studied: Subcutaneous, topical (cream/serum at 0.1-2%), intradermal

Storage: Lyophilized: store at 2-8°C. Reconstituted: 2-8°C, use within 4 weeks. Protect from light.

The GLOW Effect: Science, Not Marketing

Clavicular's reference to the "GLOW" effect when running GHK-CU is mechanistically grounded:

  • Collagen remodeling: New collagen organization improves skin texture and reduces fine lines
  • Angiogenesis: Increased capillary density improves skin color and luminosity
  • Fat loss synergy: As subcutaneous fat reduces on Retatrutide, improved skin quality becomes more visible
  • Antioxidant defense: Reduced oxidative damage maintains skin integrity during metabolic stress
The combination of GHK-CU with Retatrutide produces skin outcomes that exceed what either compound achieves alone.

Research Applications

  • Skin remodeling and collagen biology
  • Wound healing models
  • Hair follicle biology and alopecia research
  • Antioxidant and anti-aging research
  • Copper metabolism studies
  • Combined peptide stack research
Research-grade GHK-CU 50mg available from Clavicular Stack. For laboratory research use only.

Get Clavicular's Looksmaxxing Peptide Stack

Retatrutide + BPC-157 — the viral looksmaxxing protocol of 2026.